SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (96134)5/4/2000 12:50:00 PM
From: Jenna  Read Replies (2) | Respond to of 120523
 
marketgems.com 7 Strong BUYS and ENZN will turn a profit by December 2001..

On April 19, 2000 Robertson Stephens analyst Jay Silverman issued a 5 page Daily Notes Report on Enzon, Inc. Report highlights: 'The company and partner, Schering Plough, presented Phase III results for its pegylated interferon alfa-2b for the treatment of chronic hepatitis. An ATTRACTIVE rating was maintained.'

April 26: Enzon Inc ENZN ING Barings from Buy
to Strong Buy



To: Jenna who wrote (96134)5/4/2000 12:52:00 PM
From: Bob Biersack  Respond to of 120523
 
#3..3May WL up 20%